.

Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Cerilliant
AstraZeneca
UBS
Farmers Insurance
US Department of Justice
McKesson
Boehringer Ingelheim
Chubb
Dow
Accenture

Generated: September 23, 2017

DrugPatentWatch Database Preview

RASUVO Drug Profile

« Back to Dashboard

What is the patent landscape for Rasuvo, and what generic Rasuvo alternatives are available?

Rasuvo is a drug marketed by Medac Pharma Inc and is included in one NDA. There is one patent protecting this drug.

This drug has twenty-four patent family members in nineteen countries.

The generic ingredient in RASUVO is methotrexate. There are twenty drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the methotrexate profile page.

Summary for Tradename: RASUVO

Patents:1
Applicants:1
NDAs:1
Suppliers / Packagers: see list1
Bulk Api Vendors: see list74
Clinical Trials: see list1
Patent Applications: see list9,567
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:RASUVO at DailyMed

Pharmacology for Tradename: RASUVO

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Medac Pharma Inc
RASUVO
methotrexate
SOLUTION;SUBCUTANEOUS205776-001Jul 10, 2014RXNoNo► Subscribe► Subscribe ► Subscribe
Medac Pharma Inc
RASUVO
methotrexate
SOLUTION;SUBCUTANEOUS205776-007Jul 10, 2014RXNoNo► Subscribe► Subscribe ► Subscribe
Medac Pharma Inc
RASUVO
methotrexate
SOLUTION;SUBCUTANEOUS205776-004Jul 10, 2014RXNoNo► Subscribe► Subscribe ► Subscribe
Medac Pharma Inc
RASUVO
methotrexate
SOLUTION;SUBCUTANEOUS205776-008Jul 10, 2014RXNoNo► Subscribe► Subscribe ► Subscribe
Medac Pharma Inc
RASUVO
methotrexate
SOLUTION;SUBCUTANEOUS205776-002Jul 10, 2014RXNoNo► Subscribe► Subscribe ► Subscribe
Medac Pharma Inc
RASUVO
methotrexate
SOLUTION;SUBCUTANEOUS205776-003Jul 10, 2014RXNoNo► Subscribe► Subscribe ► Subscribe
Medac Pharma Inc
RASUVO
methotrexate
SOLUTION;SUBCUTANEOUS205776-006Jul 10, 2014RXNoNo► Subscribe► Subscribe ► Subscribe
Medac Pharma Inc
RASUVO
methotrexate
SOLUTION;SUBCUTANEOUS205776-005Jul 10, 2014RXNoNo► Subscribe► Subscribe ► Subscribe
Medac Pharma Inc
RASUVO
methotrexate
SOLUTION;SUBCUTANEOUS205776-010Jul 10, 2014RXNoNo► Subscribe► Subscribe ► Subscribe
Medac Pharma Inc
RASUVO
methotrexate
SOLUTION;SUBCUTANEOUS205776-009Jul 10, 2014DISCNNoNo► Subscribe► Subscribe ► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

International Patent Family for Tradename: RASUVO

Country Document Number Estimated Expiration
Japan2009544636► Subscribe
CroatiaP20110148► Subscribe
Austria491455► Subscribe
Slovenia2046332► Subscribe
Mexico2009000812► Subscribe
European Patent Office2292235► Subscribe
BrazilPI0715433► Subscribe
Denmark2046332► Subscribe
Serbia51688► Subscribe
Spain2355399► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

UBS
Deloitte
Citi
Argus Health
QuintilesIMS
Federal Trade Commission
Daiichi Sankyo
Baxter
US Army
Novartis

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot